Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sridhar Mani

Showing results (161-170 of 170) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 170 results.
Cancer Chemotherapy and Pharmacology|April 12, 2011
Dose-escalating and pharmacological study of bortezomib in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group StudyTiciana B Leal, Scot C Remick, Chris H Takimoto, et al.
Bioorganic Chemistry|February 26, 2021
Deciphering structural bases of intestinal and hepatic selectivity in targeting pregnane X receptor with indole-based microbial mimicsHao Li, Peter Illés, Chamini V Karunaratne, et al.
Gastroenterology|March 20, 2021
Bacterial Swarmers Enriched During Intestinal Stress Ameliorate DamageArpan De, Weijie Chen, Hao Li, et al.
Molecular Endocrinology (Baltimore, Md.)|December 22, 2007
The phytoestrogen coumestrol is a naturally occurring antagonist of the human pregnane X receptorHongwei Wang, Hao Li, Linda B Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2008
Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of renal dysfunction: a study by the National Cancer Institute Organ Dysfunction Working GroupJoseph Gibbons, Merrill J Egorin, Ramesh K Ramanathan, et al.
Chemistry & Biology|September 15, 2015
Structure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug ToxicityBret D Wallace, Adam B Roberts, Rebecca M Pollet, et al.
Nature Communications|February 3, 2025
An abundant ginger compound furanodienone alleviates gut inflammation via the xenobiotic nuclear receptor PXR in miceXiaojuan Wang, Guohui Zhang, Zhiwei Bian, et al.
Gut|October 21, 2022
Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel diseasesChloé Michaudel, Camille Danne, Allison Agus, et al.
Science (New York, N.Y.)|November 7, 2015
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiotaMarie Vétizou, Jonathan M Pitt, Romain Daillère, et al.
EMBO Molecular Medicine|March 11, 2020
Targeting the pregnane X receptor using microbial metabolite mimicryZdeněk Dvořák, Felix Kopp, Cait M Costello, et al.
Pageof 17

Showing results (161-170 of 170) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 170 results.
Cancer Chemotherapy and Pharmacology|April 12, 2011
Dose-escalating and pharmacological study of bortezomib in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group StudyTiciana B Leal, Scot C Remick, Chris H Takimoto, et al.
Bioorganic Chemistry|February 26, 2021
Deciphering structural bases of intestinal and hepatic selectivity in targeting pregnane X receptor with indole-based microbial mimicsHao Li, Peter Illés, Chamini V Karunaratne, et al.
Gastroenterology|March 20, 2021
Bacterial Swarmers Enriched During Intestinal Stress Ameliorate DamageArpan De, Weijie Chen, Hao Li, et al.
Molecular Endocrinology (Baltimore, Md.)|December 22, 2007
The phytoestrogen coumestrol is a naturally occurring antagonist of the human pregnane X receptorHongwei Wang, Hao Li, Linda B Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2008
Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of renal dysfunction: a study by the National Cancer Institute Organ Dysfunction Working GroupJoseph Gibbons, Merrill J Egorin, Ramesh K Ramanathan, et al.
Chemistry & Biology|September 15, 2015
Structure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug ToxicityBret D Wallace, Adam B Roberts, Rebecca M Pollet, et al.
Nature Communications|February 3, 2025
An abundant ginger compound furanodienone alleviates gut inflammation via the xenobiotic nuclear receptor PXR in miceXiaojuan Wang, Guohui Zhang, Zhiwei Bian, et al.
Gut|October 21, 2022
Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel diseasesChloé Michaudel, Camille Danne, Allison Agus, et al.
Science (New York, N.Y.)|November 7, 2015
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiotaMarie Vétizou, Jonathan M Pitt, Romain Daillère, et al.
EMBO Molecular Medicine|March 11, 2020
Targeting the pregnane X receptor using microbial metabolite mimicryZdeněk Dvořák, Felix Kopp, Cait M Costello, et al.
Pageof 17